Get the facts on diseases, conditions, tests and procedures.
Enter the last name, specialty or keyword for your search below.
Male
Languages: English, Gujarati, Hindi
Expertise: Autoimmune Diseases, Focal Segmental Glomerulosclerosis, Hyperlipidemia, Sickle Cell Disease, Stem Cell Transplants, Thrombotic Thrombocytopenic Purpura, Transplant Medicine ...read more
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287
map
Phone: 410-955-9790
Parvez M. Lokhandwala is an Assistant Professor of Pathology at the Johns Hopkins University School of Medicine. He is the Medical Director of the Hemapheresis service at the Johns Hopkins Hospital.
Dr. Lokhandwala earned his medical degree (M.B.B.S.) from M. S. University of Baroda in India, followed by a master’s degree in Molecular Genetics from University of Leicester. He received a Ph.D. in Genetics from Pennsylvania State University College of Medicine. He completed residency training in Clinical Pathology at Pennsylvania State University College of Medicine, followed by fellowship training in Molecular Genetic Pathology and Blood Bank/Transfusion Medicine at Johns Hopkins University School of Medicine.
Clinically, Dr. Lokhandwala attends on the Transfusion Medicine and the Molecular Diagnostics services at Johns Hopkins Hospital. His area of clinical expertise include the use of apheresis technology in the treatment of many diseases.
His research focuses on developing novel molecular diagnostic tests in transfusion medicine and testing novel blood products to improve the safety of blood transfusions.
Lokhandwala PM, Shike H, Wang M, Domen RE, George MR. Optimizing donor scheduling before recruitment: An effective approach to increasing apheresis platelet collections. PLoS One. 2018 May 30;13(5):e0198062. doi: 10.1371/journal.pone.0198062. eCollection 2018. PMID: 29847596
Lokhandwala PM, O'Neal A, Patel EU, Brunker PAR, Gehrie EA, Zheng G, Kickler TS, Ness PM, Tobian AAR. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing. Transfusion. 2018 May;58(5):1126-1131. doi: 10.1111/trf.14550. Epub 2018 Feb 25. PMID: 29479708
Lokhandwala PM, Shabihkhani M, Ness PM, Bloch EM. Therapeutic plasma exchange for hyperviscosity syndrome secondary to high rheumatoid factor. Transfus Apher Sci. 2018 Apr;57(2):225-227. doi: 10.1016/j.transci.2018.02.004. Epub 2018 Feb 15. PMID: 29478798
Lokhandwala PM, Riel SL, Haley L, Lu C, Chen Y, Silberstein J, Zhu Y, Zheng G, Lin MT, Gocke CD, Partin AW, Antonarakis ES, Luo J, Eshleman JR. Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory Setting. J Mol Diagn. 2017 Jan;19(1):115-125. doi: 10.1016/j.jmoldx.2016.08.003. Epub 2016 Dec 1. PMID: 27916435
Belchis DA, Tseng LH, Gniadek T, Haley L, Lokhandwala P, Illei P, Gocke CD, Forde P, Brahmer J, Askin FB, Eshleman JR, Lin MT. Heterogeneity of resistance mutations detectable by nextgeneration sequencing in TKI-treated lung adenocarcinoma. Oncotarget. 2016 Jul 19;7(29):45237-45248. doi: 10.18632/oncotarget.9931.
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
